| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/21/2004 | WO2003104426A3 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 05/21/2004 | WO2003088900A3 Solid forms of salts with tyrosine kinase activity |
| 05/21/2004 | WO2003085110A3 Oligomeric compounds for the modulation hif-1alpha expression |
| 05/21/2004 | WO2003080638A3 Antisense iap nucleobase oligomers and uses thereof |
| 05/21/2004 | WO2003080105A3 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 05/21/2004 | WO2003078601A8 Posh nucleic acids, polypeptides and related methods |
| 05/21/2004 | WO2003076584A8 Novel proteins and nucleic acids encoding same |
| 05/21/2004 | WO2003072725A3 Recombinant negative strand virus rna expression systems and vaccines |
| 05/21/2004 | WO2003072543A3 Methods of preventing or treating brain ischemia or brain injury |
| 05/21/2004 | WO2003072040A3 Administration of agents for the treatment of inflammation |
| 05/21/2004 | WO2003055440A8 Compositions and methods for the treatement of immune related diseases |
| 05/21/2004 | WO2003040296A8 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 05/21/2004 | WO2003013422A3 Methods for the treatment and prognosis of leukemia and other cancer types |
| 05/21/2004 | WO2002102306A8 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 05/21/2004 | WO2002096923B1 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
| 05/21/2004 | WO2002090361A8 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
| 05/21/2004 | WO2002074719A3 Inhibitors of plasmepsins |
| 05/21/2004 | WO2002070538A8 Narc8 programmed cell-death-associated molecules and uses thereof |
| 05/21/2004 | WO2002061105A8 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 05/21/2004 | WO2002060163A3 Methods for increasing bone formation and enhancing bone accretion |
| 05/21/2004 | WO2002058724A8 Use of lp82 to treat body weight disorders |
| 05/21/2004 | WO2002040674A9 '67118', '67067' and '62092', human proteins and methods of use thereof |
| 05/21/2004 | WO2000066068A3 Method for inducing growth and enhancing survival of nervous tissue |
| 05/21/2004 | WO2000058340A3 50 human secreted proteins |
| 05/21/2004 | WO2000032745A3 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 05/21/2004 | CA2543376A1 Interferon antagonists useful for the treatment of interferon related diseases |
| 05/21/2004 | CA2505218A1 Methods and systems for enabling and stabilizing tooth movement |
| 05/21/2004 | CA2504980A1 Method for providing natural therapeutic agents with high therapeutic index |
| 05/21/2004 | CA2504932A1 Oral formulation or botulinum toxin and use thereof for treating peptic ulcers and gastroesophageal reflux disease |
| 05/21/2004 | CA2504926A1 Compositions and methods for sirna inhibition of hif-1 alpha |
| 05/21/2004 | CA2504915A1 Allele-specific rna interference |
| 05/21/2004 | CA2504350A1 Apkc isoforms in nervous system disorders and cancer |
| 05/21/2004 | CA2504283A1 Therapeutic compositions for drug delivery to and through covering epithelia |
| 05/21/2004 | CA2504270A1 Peptide fragments of the harp factor inhibiting angiogenesis |
| 05/21/2004 | CA2504263A1 Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment and management of macular degeneration |
| 05/21/2004 | CA2504125A1 Inducible ligand for .alpha.1.beta.1 integrin and uses |
| 05/21/2004 | CA2504024A1 Composition for the treatment of macular degeneration |
| 05/21/2004 | CA2503964A1 Pain relief agents |
| 05/21/2004 | CA2503561A1 Prevention and treatment of synucleinopathic disease |
| 05/21/2004 | CA2503546A1 Pharmaceutical composition for preparing a medicine for treating and/or preventing a pathology related to an obsessive behaviour or obesity |
| 05/21/2004 | CA2503390A1 Compositions and methods for the treatment of immune related diseases |
| 05/21/2004 | CA2501523A1 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5 |
| 05/20/2004 | US20040098755 Comprises nucleotide sequences coding embryonic glycoprotein for use in the treatment and prevention of autoimmune, cell proliferative and immunological disorders; immunosuppressants; antiproliferative agents |
| 05/20/2004 | US20040097867 Systems and methods for treating patients with processed lipoaspirate cells |
| 05/20/2004 | US20040097730 Amide containing a pyridinone or pyrazinone compound as serine protease enzyme inhibitors |
| 05/20/2004 | US20040097720 Use of glycodendrimer reagents for inhibiting adhesion by microorganisms |
| 05/20/2004 | US20040097714 Using microfiltration and/or diafiltration to isolate transforming growth factor from dairy products for use in treatment and prevention of cell proliferative, autoimmune, bone and inflammatory disorders; antitumor agents |
| 05/20/2004 | US20040097706 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/20/2004 | US20040097705 Small acid-soluble spore protein and uses thereof |
| 05/20/2004 | US20040097702 Thiopeptide compounds |
| 05/20/2004 | US20040097577 Use of at least one of melatonin, a melatonin analogue, or a pharmaceutically acceptable salt of melatonin or melatonin analogue, in the preparation of a medicament for the treatment of ADHD in a mammal, especially a human being |
| 05/20/2004 | US20040097551 As inhibitors of glucosylceramide synthase; for therapy and prophylaxis |
| 05/20/2004 | US20040097540 Adenosine a2a receptor antangonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 05/20/2004 | US20040097500 Compounds and compositions for delivering active agents |
| 05/20/2004 | US20040097496 Novel thiazine derivatives |
| 05/20/2004 | US20040097469 For prophylaxis of cartilage destruction or chondrolysis associated with osteonecrosis and/or osteochondritis dissecans |
| 05/20/2004 | US20040097466 Treatment of a patient suffering from cell surface thrombosis disorders using enhanced absorption of arginine |
| 05/20/2004 | US20040097459 Modulation of forkhead box O1A expression |
| 05/20/2004 | US20040097457 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis |
| 05/20/2004 | US20040097456 Using a cytokine for prophylaxis, therapy and diagnosis of skin related growth disorders in mammals |
| 05/20/2004 | US20040097455 Cloning of reporter genes and cDNA encoding for therapeutic proteins for the treatment of hepatic, pulmonary, renal, heart, pancreas fibrosis, keloids and hypertrophic scars, in mammals, including human beings |
| 05/20/2004 | US20040097453 Introducing to the subject, or to a target group of cells from the subject, an expressible polynucleotide encoding a eukaryotic heat shock protein for stimulating a therapeutic immune response |
| 05/20/2004 | US20040097452 Modulation of kallikrein 6 expression |
| 05/20/2004 | US20040097451 Modulation of nidogen expression |
| 05/20/2004 | US20040097450 Modulation of TDP-1 expression |
| 05/20/2004 | US20040097449 Modulation of KIAA0415 expression |
| 05/20/2004 | US20040097448 Modulation of CD24 expression |
| 05/20/2004 | US20040097447 For therapy of autoimmune disorder |
| 05/20/2004 | US20040097446 Modulation of checkpoint kinase 1 expression |
| 05/20/2004 | US20040097445 For therapy of hyperproliferative disorder |
| 05/20/2004 | US20040097444 Modulation of serine/threonine kinase 16 expression |
| 05/20/2004 | US20040097443 Modulation of jerky-like 1 expression |
| 05/20/2004 | US20040097441 Modulation of NIMA-related kinase 6 expression |
| 05/20/2004 | US20040097438 Fused-ring compounds and use thereof as drugs |
| 05/20/2004 | US20040097426 Prevent muscle degradation; arginine-glutamine dipeptide |
| 05/20/2004 | US20040097425 Peptide compounds |
| 05/20/2004 | US20040097422 Methods of use for tripeptidyl peptidase II inhibitors as anticancer agents |
| 05/20/2004 | US20040097421 Melphalan derivatives and their use as cancer chemotherapeutic drugs |
| 05/20/2004 | US20040097420 Proteasome regulation of NF-kB activity |
| 05/20/2004 | US20040097417 Nerve growth factor with acetate buffer |
| 05/20/2004 | US20040097416 Analgesics; neuropathic pain; bipolar disorders |
| 05/20/2004 | US20040097415 Controlling blood glucose concentration; amylin antagonist |
| 05/20/2004 | US20040097414 Genetic engineered Dna; gene therapy |
| 05/20/2004 | US20040097413 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 05/20/2004 | US20040097412 Non-mammalian GnRH analogs and uses thereof in tumor cell growth regulation and cancer therapy |
| 05/20/2004 | US20040097411 Administering glucagen-like peptide |
| 05/20/2004 | US20040097410 Dissolving drug in acidic aqueous buffered solution; adding surfactant and oil; agitation; oral administering |
| 05/20/2004 | US20040097404 Supplement to be enternally administered for parenteral nutrition or partial enteral/oral nurtrition of the critically ill, the chronically ill and people with malnutrition |
| 05/20/2004 | US20040097403 Linkable sialyl lewis x analogs |
| 05/20/2004 | US20040097402 Therapy for infections; bactericides; synergistic mixtures |
| 05/20/2004 | US20040096965 Activator of fibronectin binding protein and method of its preparation |
| 05/20/2004 | US20040096956 Trangenic cells for generation of immunoglobulins for detection, quantitation, purification and neutralization of antigens; therapeutic diagnostics |
| 05/20/2004 | US20040096955 Methods and compositions for determining isomerase enzymatic activity |
| 05/20/2004 | US20040096953 Thrombin derivatives and process for producing the same, anhydrothrombin derivatives and process for producing the same, platelet agglutination-inducing composition, method of inducing platelet agglutination, clinical test reagents, clinical test method, thrombosis inhibitors, adsorbent and process for producing the same, |
| 05/20/2004 | US20040096945 Nucleic acids and protein variants of hG-CSF with granulopoietic activity |
| 05/20/2004 | US20040096940 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
| 05/20/2004 | US20040096939 Modifier of organelle metabolism |
| 05/20/2004 | US20040096936 Comprises nucleotide sequences coding fibroblast growth factor (FGF) for treating cardiac disorders; tissue engineering; tissue-targeted gene therapy |
| 05/20/2004 | US20040096935 Antibodies against interleukin-17 receptor like protein |
| 05/20/2004 | US20040096921 Human plasma hyaluronidase |